By Charles Toutant | September 25, 2017
While state and local governments are filing a profusion of suits against drug companies to recoup costs of the opioid crisis, the trend has been slow to take hold in New Jersey. But opioid litigation is seen as having strong prospects if it can zero in on malfeasance by drug manufacturers and distributors, some observers said.
By Zack Needles | September 22, 2017
The U.S. Court of Appeals for the Third Circuit has let stand its August ruling upholding the dismissal of antitrust claims against GlaxoSmithKline.
By Amanda Bronstad | September 21, 2017
Tuesday's ruling by Cook County Circuit Court Judge Deborah Mary Dooling reversed a 2013 defense verdict that came out just before DePuy reached a $2.5 billion global settlement resolving about 8,000 cases.
By Max Mitchell | September 20, 2017
Pharmaceutical giant Pfizer has sued rival Johnson & Johnson over claims the company forced health care providers and insurers into exclusionary contracts aimed at blocking a competing autoimmune medication Pfizer recently introduced into the market.
New Jersey Law Journal | Analysis
By njlawjournal | September 18, 2017
In the Law Journal's Intellectual Property & Life Sciences supplement, articles focus on the new challenges presented by 3D printing, and the…
By Jean E. Dassie and Christine A. Gaddis | September 18, 2017
On May 22, the Supreme Court of the United States decided 'TC Heartland v. Kraft Foods Group Brands,' which fundamentally changed the patent venue landscape.
By Gerard P. Norton and Michael S. Montgomery | September 18, 2017
On June 12, the U.S. Supreme Court issued a unanimous opinion in 'Sandoz v. Amgen,' a highly anticipated case concerning key provisions of the Biologics Price Competition and Innovation Act, part of the larger Patient Protection and Affordable Care Act of 2009.
By Max Mitchell | September 13, 2017
The judge overseeing pelvic mesh mass tort litigation said the New Jersey-based defendant may have had a "strong" relationship with a Pennsylvania mesh-manufacturer, but he questioned whether that relationship would be enough to allow the Keystone State to retain jurisdiction over 90 pelvic mesh cases involving out-of-state plaintiffs.
By Tom McParland | September 13, 2017
The former head of Valeant Pharmaceuticals International Inc.' s dermatology division was unable to convince a court to end a class action lawsuit accusing the generic drugmaker and its executives of engaging in a massive scheme to fraudulently inflate the company's stock prices.
By Sue Reisinger | August 24, 2017
Michael Ullmann, general counsel of Johnson & Johnson will have a lot to think about in the aftermath of the massive verdict.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...